Mediation of human immunodeficiency virus type 1 binding by interaction of cell surface heparan sulfate proteoglycans with the V3 region of envelope gp120-gp41.
about
cis Expression of DC-SIGN allows for more efficient entry of human and simian immunodeficiency viruses via CD4 and a coreceptorHuman immunodeficiency virus and heparan sulfate: from attachment to entry inhibitionRole of heparan sulfate in sexually transmitted infectionsThe furin protease cleavage recognition sequence of Sindbis virus PE2 can mediate virion attachment to cell surface heparan sulfateSpecific interaction of CCR5 amino-terminal domain peptides containing sulfotyrosines with HIV-1 envelope glycoprotein gp120Lignosulfonic acid exhibits broadly anti-HIV-1 activity--potential as a microbicide candidate for the prevention of HIV-1 sexual transmissionOral and vaginal epithelial cell lines bind and transfer cell-free infectious HIV-1 to permissive cells but are not productively infected.Human immunodeficiency virus type 1 attachment to HeLa CD4 cells is CD4 independent and gp120 dependent and requires cell surface heparans.Cytokine regulation of human immunodeficiency virus type 1 entry and replication in human monocytes/macrophages through modulation of CCR5 expression.Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120Binding of recombinant feline immunodeficiency virus surface glycoprotein to feline cells: role of CXCR4, cell-surface heparans, and an unidentified non-CXCR4 receptor.Syndecans serve as attachment receptors for human immunodeficiency virus type 1 on macrophages.Syndecan-Fc hybrid molecule as a potent in vitro microbicidal anti-HIV-1 agent.Receptors and entry cofactors for retroviruses include single and multiple transmembrane-spanning proteins as well as newly described glycophosphatidylinositol-anchored and secreted proteins.Contribution of proteoglycans to human immunodeficiency virus type 1 brain invasion.Macrophage-tropic simian/human immunodeficiency virus chimeras use CXCR4, not CCR5, for infections of rhesus macaque peripheral blood mononuclear cells and alveolar macrophagestrans-Complementation rescue of cyclophilin A-deficient viruses reveals that the requirement for cyclophilin A in human immunodeficiency virus type 1 replication is independent of its isomerase activityHeparanase is a host enzyme required for herpes simplex virus-1 release from cells.Sequential immunization with V3 peptides from primary human immunodeficiency virus type 1 produces cross-neutralizing antibodies against primary isolates with a matching narrow-neutralization sequence motif.Selective interaction of heparin with the variable region 3 within surface glycoprotein of laboratory-adapted feline immunodeficiency virusHeparan sulfate modification of the transmembrane receptor CD47 is necessary for inhibition of T cell receptor signaling by thrombospondin-1.Inhibition of HIV Env binding to cellular receptors by monoclonal antibody 2G12 as probed by Fc-tagged gp120.Peptide-derivatized SB105-A10 dendrimer inhibits the infectivity of R5 and X4 HIV-1 strains in primary PBMCs and cervicovaginal histoculturesIdentification of amino acid residues important for heparan sulfate proteoglycan interaction within variable region 3 of the feline immunodeficiency virus surface glycoprotein.Sulfated carbohydrate compounds prevent microbial adherence by sexually transmitted disease pathogens.Microbial adherence to and invasion through proteoglycansEffect of lysine to arginine mutagenesis in the V3 loop of HIV-1 gp120 on viral entry efficiency and neutralization.Cell-free human immunodeficiency virus type 1 transcytosis through primary genital epithelial cellsRole of EXT1 and Glycosaminoglycans in the Early Stage of Filovirus Entry.The HIV-1 envelope glycoprotein gp120 features four heparan sulfate binding domains, including the co-receptor binding site.Human immunodeficiency virus type 1 infection of SK-N-MC cells: domains of gp120 involved in entry into a CD4-negative, galactosyl ceramide/3' sulfo-galactosyl ceramide-positive cell lineThe receptor-binding domain of pseudorabies virus glycoprotein gC is composed of multiple discrete units that are functionally redundant.Proline-rich tandem repeats of antibody complementarity-determining regions bind and neutralize human immunodeficiency virus type 1 particlesNeutralizing antibodies against the V3 loop of human immunodeficiency virus type 1 gp120 block the CD4-dependent and -independent binding of virus to cells.Structural Determinants for the Selective Anti-HIV-1 Activity of the All-β Alternative Conformer of XCL1.Transmembrane TNF-α Facilitates HIV-1 Infection of Podocytes Cultured from Children with HIV-Associated Nephropathy.The proteoglycan repertoire of lymphoid cellsHuman beta-defensins 2 and -3 cointernalize with human immunodeficiency virus via heparan sulfate proteoglycans and reduce infectivity of intracellular virions in tonsil epithelial cellsHuman T-cell leukemia virus type 1 envelope glycoprotein gp46 interacts with cell surface heparan sulfate proteoglycansPolyclonal immunoglobulin G from patients neutralizes human immunodeficiency virus type 1 primary isolates by binding free virions, but without interfering with an initial CD4-independent attachment of the virus to primary blood mononuclear cells.
P2860
Q24530658-518AD2D4-FD7D-4720-B536-D20D42F0BAB9Q27004059-71D78BDD-8B51-49FA-9C09-3178C7DF2CA4Q27023959-606B6A10-545C-40DA-915B-7801462F498CQ27469718-623E21C0-EA2B-4A5E-AAD2-70422920D71FQ28344310-C6C71A86-1056-4FE4-B036-8736F58587C4Q28482818-00FD6EE5-1BD0-447A-896B-52A9DF559D37Q33654841-64BAA94A-5B45-4FED-B2E0-F8CFA7F0F2FAQ33782608-7DE6EEBE-9E94-4391-9628-D8B5B34DFC50Q33784084-3C1BFA4B-A6CA-408B-9E47-5E9067C4A265Q33797964-7E358A9F-D9F5-4804-92CE-9631EF7A871AQ33840312-F11A91FE-FF8A-44C8-BB16-D28C37010066Q33845503-55C53D9F-3BA4-4D84-8F39-F49A058D237AQ33962742-89BA7AE4-BDA3-4918-8B7C-CF6492E9BD5DQ34010373-CAF452BC-2B2C-4F05-9E83-499A1F99D92AQ34193846-13613DCA-3D3E-4505-8D23-08557F839113Q34226885-22791497-E146-41AA-9541-9B98992319BAQ34331870-5D44E2D0-6F31-4535-BD24-256F640C31DAQ34473624-A3D837D1-E67F-42F9-A987-EDA68B064F74Q34648342-FF09197A-3B5E-4B72-B820-B0382522054AQ34734101-4E37CDED-6C6F-4B45-9B88-2CB5B665AB5EQ34869450-346BB79E-1CA0-48AE-A206-ADAC0947084AQ34983331-EC9659AE-811B-4574-AED3-765F223BAA0FQ35014689-4B5D5A91-E710-4BB3-A605-25721CA1E13BQ35077801-AA9809A7-F27F-4694-B6E8-0073F9A38B25Q35139547-0A45BC05-726B-4174-935F-044A3572AD16Q35533138-BB9D678A-86B4-41AB-B5A9-ECA7B529C17CQ35580330-ACB63230-ED0A-4B7E-9109-667DB34737A6Q35634313-BD7DF4F8-0258-47D9-A8BB-64D468E53F3CQ35641426-F11FD52A-358B-4314-A997-C49F03FD0368Q35674470-4C7503A6-7F4E-44D5-84BF-F89B2FECA217Q35851603-62D22C6D-F4AA-40F4-9288-29C6853892E9Q35855824-D16CBC6D-82C3-4928-843E-0E34D350D484Q35869342-475450B8-51F6-4B61-BC2E-DCDDCC0B5FCCQ35898116-8CA6FBA4-1F10-4B92-B81B-2C0468E6E073Q35913867-DFB93753-BD99-48D2-AE8A-212CB0BF8E00Q36181815-97866818-5800-4469-B77F-E40CD6418B9CQ36208202-9AC6D691-D9A4-4C57-989A-59B5434B46E7Q36373244-93CF99F9-5E9D-4E8C-BD05-EEBA9FEA3C16Q36464718-7374C676-EFDB-4D67-BA21-C3FFB01C2A8FQ36541239-16C07352-E298-4162-B38D-E8EA0324EEDF
P2860
Mediation of human immunodeficiency virus type 1 binding by interaction of cell surface heparan sulfate proteoglycans with the V3 region of envelope gp120-gp41.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Mediation of human immunodefic ...... region of envelope gp120-gp41.
@ast
Mediation of human immunodefic ...... region of envelope gp120-gp41.
@en
type
label
Mediation of human immunodefic ...... region of envelope gp120-gp41.
@ast
Mediation of human immunodefic ...... region of envelope gp120-gp41.
@en
prefLabel
Mediation of human immunodefic ...... region of envelope gp120-gp41.
@ast
Mediation of human immunodefic ...... region of envelope gp120-gp41.
@en
P2093
P2860
P1433
P1476
Mediation of human immunodefic ...... region of envelope gp120-gp41
@en
P2093
Bou-Habib DC
Mostowski H
Norcross MA
Roderiquez G
Yanagishita M
P2860
P304
P407
P577
1995-04-01T00:00:00Z